| 02/02 | Athersys to Host Business Update Conference Call on February 14th |  |
| 30/01 | Athersys to Participate in International Stroke Conference and BioProcess International | |
| 25/01 | Athersys, Inc / New: Other Events (form 8-K) | |
| 11/01 | Athersys to Participate in Advanced Therapies Week and Allogeneic Cell Therapies Summit.. | |
| 09/01 | Athersys Provides MultiStem Clinical Update | |
| 09/01 | Athersys, Inc. Provides an Update on Ongoing Clinical Trials with MultiStem for the Tre.. | |
| 05/01 | Athersys, Inc / New: Change in Directors or Principal Officers (form 8-K) | |
| 05/01 | Athersys Appoints Joseph Nolan to Its Board of Directors | |
| 05/01 | Athersys, Inc. Appoints Joseph Nolan to Its Board of Directors | |
| 2022 | Athersys, Inc / New: Notice of Delisting or Failure to Satisfy a Continued Listing Rule o.. | |
| 2022 | Athersys Reports Third Quarter 2022 Financial Results and Provides Business Update | |
| 2022 | ATHERSYS, INC / NEW Management's Discussion and Analysis of Financial Condition and Re.. | |
| 2022 | Athersys, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sep.. | |
| 2022 | Athersys to Present at Challenges and Opportunities for Mesenchymal Stem Cells Digital .. | |
| 2022 | Athersys Inc. Announces Closing of $5.5 Million Confidentially Marketed Public Offering | |
| 2022 | Athersys to Present at Challenges and Opportunities for Mesenchymal Stem Cells Digital .. | |
| 2022 | Athersys, Inc. Announces Closing of $5.5 Million Confidentially Marketed Public Offerin.. | |
| 2022 | Athersys: Securities Purchase Agreement - Form 8-K | |
| 2022 | Athersys, Inc / New: Entry into a Material Definitive Agreement, Other Events, Financial .. | |
| 2022 | Athersys Reschedules Third Quarter Conference Call to November 15 | |
| 2022 | Athersys Prices $5.5 Million Public Offering; Shares Slump | |
| 2022 | Athersys, Inc. Announces Pricing of $5.5 Million Public Offering | |
| 2022 | Sector Update: Health Care Stocks Advance During Tuesday Trading | |
| 2022 | Sector Update: Health Care Receiving Strong Support Again on Tuesday | |
| 2022 | Top Premarket Decliners | |
| 2022 | US Futures Move Cautiously Higher as American Head to Polls for Midterms | |
| 2022 | Athersys, Inc. Announces Proposed Public Offering | |
| 2022 | Athersys Announces Public Offering Plan | |
| 2022 | Athersys, Inc / New: Change in Directors or Principal Officers (form 8-K) | |
| 2022 | Athersys, Inc. Announces the Resignation of Kenneth H. Traub from the Board of Directo.. | |
| 2022 | Scynexis Names Ivor Macleod CFO | |
| 2022 | Athersys to Host Third Quarter Financial Results Call | |
| 2022 | Athersys, Inc / New: Notice of Delisting or Failure to Satisfy a Continued Listing Rule o.. | |
| 2022 | Athersys to Present at 2022 Cell and Gene Meeting on the Mesa Conference and Attend 14t.. | |
| 2022 | Athersys to Present at 2022 Cell & Gene Meeting on the Mesa Conference and Attend 14th .. | |
| 2022 | Athersys to Host Business Update Conference Call on October 6th | |
| 2022 | Athersys to Host Business Update Conference Call on October 6th | |
| 2022 | Sector Update: Health Care Stocks Paring Losses in Late Uptick | |
| 2022 | Sector Update: Health Care | |
| 2022 | Top Midday Gainers | |
| 2022 | Athersys Amends Securities Purchase Agreement in Connection with Recent Registered Dire.. | |
| 2022 | Athersys, Inc / New: Entry into a Material Definitive Agreement, Unregistered Sale of Equ.. | |
| 2022 | Athersys, Inc.(NasdaqCM:ATHX) dropped from S&P Global BMI Index | |
| 2022 | Athersys: Current Report - Form 8-K | |
| 2022 | Athersys, Inc / New: Other Events (form 8-K) | |
| 2022 | Athersys, Inc / New: Other Events (form 8-K) | |
| 2022 | Athersys, Inc / New: Material Modification to Rights of Security Holders, Amendments to A.. | |
| 2022 | Wall Street Set to Open Higher Ahead of Powell's Outlook in Jackson Hole | |
| 2022 | US Futures Lower Ahead of Fed Chair Powell's Outlook | |
| 2022 | Top Premarket Decliners | |
| 2022 | Athersys to Launch 1-for-25 Reverse Stock Split; Shares Drop | |
| 2022 | Athersys Announces 1-for-25 Reverse Stock Split | |
| 2022 | Athersys Raises $12 Million From Registered Direct Offering of Common Stock, Warrants | |
| 2022 | Athersys, Inc. Announces Closing of $12 Million Registered Direct Offering | |
| 2022 | Athersys, Inc / New: Entry into a Material Definitive Agreement, Financial Statements and.. | |
| 2022 | Athersys: Securities Purchase Agreement - Form 8-K | |
| 2022 | Athersys Signs $12 Million Registered Direct Offering | |
| 2022 | Athersys, Inc. Announces $12 Million Registered Direct Offering | |
| 2022 | ATHERSYS, INC / NEW Management's Discussion and Analysis of Financial Condition and Re.. | |
| 2022 | Athersys: REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE - Fo.. | |
| 2022 | Athersys Reports Second Quarter 2022 Financial Results and Provides Business Update | |
| 2022 | Earnings Flash (ATHX) ATHERSYS Posts Q2 Revenue $2.3M | |
| 2022 | Athersys, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2022 | |
| 2022 | Athersys Announces Favorable Preclinical Results for MultiStem® Treatment in Defense De.. | |
| 2022 | Athersys, Inc. Announces Favorable Preclinical Results for MultiStem Treatment in Defen.. | |
| 2022 | Athersys, Inc / New: Change in Directors or Principal Officers (form 8-K) | |
| 2022 | Athersys Appoints Kasey Rosado as Interim Chief Financial Officer | |
| 2022 | Athersys, Inc. Appoints Kasey Rosado as Interim Chief Financial Officer | |
| 2022 | Athersys, Inc / New: Change in Directors or Principal Officers, Submission of Matters to .. | |
| 2022 | Athersys to Host Second Quarter Financial Results Call | |
| 2022 | Athersys Says Equity Purchase Deal With Aspire Capital Fund Has Been Terminated | |
| 2022 | Athersys: Termination of a Material Definitive Agreement - Form 8-K | |
| 2022 | Athersys, Inc / New: Termination of a Material Definitive Agreement, Change in Directors .. | |
| 2022 | Athersys and Aspire Capital Fund Terminate Relationship | |
| 2022 | Athersys, Inc. Designates Dan Camardo as the Principal Financial Officer and Principal .. | |
| 2022 | Athersys, Inc. cancelled the transaction announced on May 12, 2022 | |
| 2022 | Athersys, Inc / New: Change in Directors or Principal Officers (form 8-K) | |
| 2022 | Athersys, Inc. Announces Board Changes | |
| 2022 | Athersys Announces Board of Directors Slate for 2022 Annual Meeting of Stockholders and.. | |
| 2022 | Wall Street Set to Open Higher | |
| 2022 | US Futures Move Higher Friday | |
| 2022 | Top Premarket Gainers | |
| 2022 | Athersys: POSTPONES ANNUAL MEETING OF STOCKHOLDERS - Form 8-K | |
| 2022 | Athersys, Inc / New: Shareholder Director Nominations, Other Events, Financial Statements.. | |
| 2022 | Athersys Postpones Annual Meeting of Stockholders | |
| 2022 | Athersys Hosting KOL Panel Event to Discuss TREASURE Data | |
| 2022 | Athersys Reducing Workforce by 70% to Cut Costs -- Shares Fall 7% After-Hours | |
| 2022 | Athersys: ANNOUNCES THAT ITS PARTNER, HEALIOS K.K., REPORTED TOPLINE DATA FROM THE TREASU.. | |
| 2022 | Athersys, Inc / New: Costs Associated with Exit or Disposal Activities, Change in Directo.. | |
| 2022 | Athersys Announces Restructuring and Management Changes to Focus on Its Existing Clinic.. | |
| 2022 | Athersys, Inc. Announces Resignation of Ivor Macleod as Chief Financial Officer, Effect.. | |
| 2022 | Athersys, Inc. Announces Management Changes | |
| 2022 | Top Midday Decliners | |
| 2022 | Athersys Shares Drop After BofA Securities Downgrade | |
| 2022 | Athersys Shares Tumble Pre-Bell as MultiStem Study Misses Primary Endpoint | |
| 2022 | Top Premarket Decliners | |
| 2022 | Athersys Announces That Its Partner, HEALIOS K.K., Reported Topline Data From the TREAS.. | |
| 2022 | Athersys to Participate in the H.C. Wainwright Global Investment Conference | |
| 2022 | Athersys, Inc / New: Entry into a Material Definitive Agreement, Financial Statements and.. | |
| 2022 | Athersys, Inc. announced that it expects to receive $100 million in funding from Aspire.. | |
Google
Twitter
Facebook
Apple
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Nederlands (Nederland)
Nederlands (België)
Rapporto
